Splash Beverage Group Announces Strategic Investment in Avicanna Inc.

Splash Beverage Group, Inc. has announced a strategic investment of CDN$300,000 in Avicanna Inc., a cannabinoid-based biopharmaceutical company. This investment aligns with Splash Beverage Group's transformation into a platform focused on health, wellness, and healthcare within the cannabinoid sector. Avicanna Inc. is recognized for its sophisticated cannabinoid healthcare platform, proprietary formulations, clinical research, and pharmaceutical products, including Trunerox™ for epilepsy. The company also operates MyMedi.ca, a medical cannabis care platform in Canada, and possesses a vertically integrated international platform for pharmaceutical-grade cannabinoid manufacturing. Splash Beverage Group believes Avicanna is well-positioned due to its clinical evidence, physician participation, healthcare integration, and regulatory compliance, which may be crucial as the U.S. healthcare and regulatory environment evolves.